CDMF version) [17, 18], Diabetes Complication Severity Index (DCSI) [19, 20], common comorbidities (yes/no), common concomitant drug classes (yes/no), diseases/conditions related to weight changes, medications associated with weight gain (yes/no), number of glucose-lowering medications, glucose-lowering drug class at baseline, common procedures (yes/no), number of all-cause hospitalizations (60 days before index date), number of all-cause emergency department visits (60 days before index date), baseline out-of-pocket costs for all prescription drugs, and number of follow-up days amid the COVID-19 pandemic (i.e., follow-up days after March 1, 2020)
Regmi, S., Fu, A., & Luo, K
In addition to extracellular catabolism, intracellular GSH degradation is mediated by the ChaC GSH specific gamma-glutamylcyclotransferase family (CHAC1 and CHAC2), which cleaves GSH into 5-oxoproline and Cys-Gly 28,29
The difference from placebo (95% CI) for OZEMPIC 0.5 mg was -2.6 kg (-3.8, -1.5), and for OZEMPIC 1 mg was -3.5 kg (-4.8, -2.2)
The Price: Expect to Pay $299 There has been a lot of advertising about a $149 price point
